当前位置: 首页 > 详情页

Epigallocatechin-3-gallate stimulates autophagy and reduces apoptosis levels in retinal Müller cells under high-glucose conditions

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [a]The Second Affiliated Hospital of Soochow University. Suzhou, 215004, China [b]Department of Ophthalmology, Lixiang Eye Hospital of Soochow University, Suzhou, 215021, China [c]Shanghai Key Laboratory of Fundus Disease, Shanghai, 200080, China [d]Department of Ophthalmology, Shanghai First People's Hospital, School of Medicine, Shanghai JiaoTong University, 100 Haining Road, Shanghai, 200080, China
出处:
ISSN:

关键词: Apoptosis Autophagy Diabetes retinopathy EGCG Müller cells

摘要:
Retinal neurodegeneration is an early feature in the pathogenesis of diabetic retinopathy (DR). Autophagy is an intracellular catabolic process involved in protein and organelle degradation that has been linked in DR. Epigallocatechin gallate (EGCG) is a major polyphenol in green tea that has beneficial effects in diabetic. however, it is not currently known whether EGCG can regulate Müller cell autophagy. Here, we showed that EGCG increased autophagy by promoting the formation of autophagosomes, increasing lysosomal acidification, and stimulating autophagic flux in Müller cells, while high glucose (HG) induced a decrease in autophagy and an increase in apoptosis. However, retinal Müller cells in HG treated with EGCG showed autophagy machinery activation and reestablishment of cargo degradation, protecting the cells from apoptosis. EGCG could increase the ability of cells to proliferate by increasing autophagy. In an experimental model of diabetic retinopathy, EGCG reduced the reactive gliosis of Müller cells and decreased retinal damage. These results highlight that HG downregulates autophagy and accumulates P62 cargo due to lysosomal dysfunction and then increases apoptosis, which was reversed by treatment with EGCG. This finding might be valuable for developing a novel therapeutic strategy to treat DR. © 2019 Elsevier Inc.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 2 区 医学
小类 | 3 区 细胞生物学 3 区 肿瘤学
最新[2023]版:
大类 | 3 区 生物学
小类 | 4 区 细胞生物学 4 区 肿瘤学
JCR分区:
出版当年[2017]版:
Q2 ONCOLOGY Q3 CELL BIOLOGY
最新[2023]版:
Q2 ONCOLOGY Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [a]The Second Affiliated Hospital of Soochow University. Suzhou, 215004, China [b]Department of Ophthalmology, Lixiang Eye Hospital of Soochow University, Suzhou, 215021, China
通讯作者:
通讯机构: [*1]Department of Ophthalmology, Lixiang Eye Hospital of Soochow University, Ganjiang East Road 200, Suzhou, 215021, China. [*2]Shanghai Key Laboratory of Fundus Disease, Shanghai, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院